Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple frailty quiz may help predict chemo risks for seniors with stomach or bowel cancer

NCT ID NCT07184047

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 40 times

Summary

This study looked at whether two simple frailty questionnaires (G8 and VES-13) can predict serious side effects from chemotherapy in people 65 and older with gastrointestinal cancers. Researchers followed 72 patients receiving standard chemotherapy and checked their frailty, nutrition, and muscle health over time. The goal is to help doctors tailor treatment to reduce harm in older, more vulnerable patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALNUTRITION ELDERLY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Etlik City Hospital, Medical Oncology Department

    Ankara, Yenimahalle, 06210, Turkey (Türkiye)

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors identify which older patients are more likely to have severe side effects from chemotherapy, allowing for more personalized treatment plans.

What could go wrong

This is a small, single-center observational study, not a treatment trial. The results may not apply to all patients or settings, and the frailty scales may not be accurate enough to change practice.

Conditions

The condition(s) this trial relates to.

biliary tract cancer Biliary Tract Neoplasms chemotherapy-induced toxicity colorectal cancer colorectal neoplasm digestive system cancer digestive system neoplasm esophageal cancer Esophageal Neoplasms Frailty gastric cancer gastric neoplasm malignant pancreatic neoplasm Malnutrition nutritional deficiency disease sarcoglycanopathy Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.